Cargando…
Recurrent respiratory papillomatosis: A 2020 perspective
OBJECTIVE: Despite recent advancement recurrent respiratory papillomatosis (RRP) remains a rare but challenging benign airway neoplasm. In recent years there has been significant shifts in incidence of this disease due to changes in vaccination and prevention for human papilloma virus (HPV) and its...
Autores principales: | Benedict, Jacob J., Derkay, Craig S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035938/ https://www.ncbi.nlm.nih.gov/pubmed/33869767 http://dx.doi.org/10.1002/lio2.545 |
Ejemplares similares
-
Systemic Use of Bevacizumab for Recurrent Respiratory Papillomatosis: Who, What, Where, When, and Why?
por: Derkay, Craig S., et al.
Publicado: (2022) -
Recurrent respiratory papillomatosis: current and future perspectives
por: Carifi, Marco, et al.
Publicado: (2015) -
Age of Child, More than HPV Type, Is Associated with Clinical Course in Recurrent Respiratory Papillomatosis
por: Buchinsky, Farrel J., et al.
Publicado: (2008) -
Recurrent respiratory papillomatosis with lung involvement
por: Molodtsova, Valentina, et al.
Publicado: (2018) -
Recurrent respiratory papillomatosis: the role of cidofovir
por: Tran, Mai Ngoc, et al.
Publicado: (2018)